Torrance-based NovaDigm Therapeutics, a stealth biomedical firm developing vaccines and therapeutics for the treatment of infections, has quietly raised $4M in funding. Backers of the firm include Domain Associates; it also appears that the firm has previously received funding from KPCB Pandemic and Biodefense Fund from Kleiner Perkins Caufield & Byers. The funding amount was disclosed in quarterly funding numbers from the PricewaterhouseCoopers/NVCA MoneyTree survey earlier this month. More information »